Patents by Inventor Jeremy D. Paulsen

Jeremy D. Paulsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277704
    Abstract: A disinfectant composition that contains a unique combination of a primary antiviral agent and a secondary antiviral agent is provided. More particularly, the primary antiviral agent includes a polyprotic acid having a low first acid dissociation constant and the secondary antiviral agent is selected from the group consisting of an anionic N-acyl compound, metal halide salt, amine compound, amine compound, aliphatic amine oxide, alkyl glycoside, alcohol ethoxylate, and combinations thereof. By selectively controlling the particular nature of each antiviral agent and their relative concentration, the present inventors have discovered that a synergistic affect can be achieved in which the disinfectant composition is capable of exhibiting an antiviral efficacy against non-enveloped viruses.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 7, 2023
    Inventors: Douglas R. Hoffman, Amy L. Vanden Heuvel, Jeremy D. Paulsen, Paige N. Anunson, Lisa M. Kroll, Corey T. Cunningham, David W. Koenig
  • Publication number: 20210092949
    Abstract: A disinfectant composition that is capable of inactivating non-enveloped viruses as well as other microorganisms, such as gram negative and gram positive bacteria, fungi, parasites, enveloped viruses, etc., is provided. Through selective control over the nature of the acid(s) employed and the overall pH level, the present inventors have discovered that the composition can achieve rapid antiviral efficacy, particularly against non-enveloped viruses. Once applied to a surface (e.g., hard surface), the disinfectant composition forms a film that remains capable of providing residual antiviral activity. Notably, the present inventors have discovered that the use of a vinylpyrrolidone copolymer in combination with a polyquaternary ammonium polymer and cationic surfactant can have a synergistic effect on the stability of the film such that it can also achieve long-term, residual antiviral activity.
    Type: Application
    Filed: December 4, 2020
    Publication date: April 1, 2021
    Inventors: Amy L. Vanden Heuvel, Douglas R. Hoffman, Jeremy D. Paulsen, Rebecca Vongsa, Paige N. Anunson, Lisa M. Kroll, Corey T. Cunningham, David W. Koenig
  • Patent number: 10874100
    Abstract: A disinfectant composition that is capable of inactivating non-enveloped viruses as well as other microorganisms, such as gram negative and gram positive bacteria, fungi, parasites, enveloped viruses, etc., is provided. Through selective control over the nature of the acid(s) employed and the overall pH level, the present inventors have discovered that the composition can achieve rapid antiviral efficacy, particularly against non-enveloped viruses. Once applied to a surface (e.g., hard surface), the disinfectant composition forms a film that remains capable of providing residual antiviral activity. Notably, the present inventors have discovered that the use of a vinylpyrrolidone copolymer in combination with a polyquaternary ammonium polymer and cationic surfactant can have a synergistic effect on the stability of the film such that it can also achieve long-term, residual antiviral activity.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: December 29, 2020
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Amy L. Vanden Heuvel, Douglas R. Hoffman, Jeremy D. Paulsen, Rebecca Vongsa, Paige N. Anunson, Lisa M. Kroll, Corey T. Cunnington, David W. Koenig
  • Publication number: 20180199567
    Abstract: A disinfectant composition that is capable of inactivating non-enveloped viruses as well as other microorganisms, such as gram negative and gram positive bacteria, fungi, parasites, enveloped viruses, etc., is provided. Through selective control over the nature of the acid(s) employed and the overall pH level, the present inventors have discovered that the composition can achieve rapid antiviral efficacy, particularly against non-enveloped viruses. Once applied to a surface (e.g., hard surface), the disinfectant composition forms a film that remains capable of providing residual antiviral activity. Notably, the present inventors have discovered that the use of a vinylpyrrolidone copolymer in combination with a polyquaternary ammonium polymer and cationic surfactant can have a synergistic effect on the stability of the film such that it can also achieve long-term, residual antiviral activity.
    Type: Application
    Filed: July 27, 2015
    Publication date: July 19, 2018
    Inventors: Amy L. Vanden Heuvel, Douglas R. Hoffman, Jeremy D. Paulsen, Rebecca Vongsa, Paige N. Anunson, Lisa M. Kroll, Corey T. Cunnington, David W. Koenig
  • Publication number: 20180200397
    Abstract: A disinfectant composition that contains a unique combination of a primary antiviral agent and a secondary antiviral agent is provided. More particularly, the primary antiviral agent includes a polyprotic acid having a low first acid dissociation constant and the secondary antiviral agent is selected from the group consisting of an anionic N-acyl compound, metal halide salt, amine compound, amine compound, aliphatic amine oxide, alkyl glycoside, alcohol ethoxylate, and combinations thereof. By selectively controlling the particular nature of each antiviral agent and their relative concentration, the present inventors have discovered that a synergistic affect can be achieved in which the disinfectant composition is capable of exhibiting an antiviral efficacy against non-enveloped viruses.
    Type: Application
    Filed: July 27, 2015
    Publication date: July 19, 2018
    Inventors: Douglas R. Hoffman, Amy L. Vanden Heuvel, Jeremy D. Paulsen, Paige N. Anunson, Lisa M. Kroll, Corey T. Cunnington, David W. Koenig
  • Patent number: 9480633
    Abstract: The present invention relates to a single phase temperature management composition. The composition includes from 0.01% to 10% by weight of a neurosensory agent and from 0.01% to 30% by weight of an antiperspirant component. The composition also includes a polar carrier where the polar carrier includes water and monohydric alcohol. The ratio of water to monohydric alcohol ranges from 0.0625:1 to 1.5:1. The compositions of the invention have a viscosity at room temperature of less than 2500 centipoise.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: November 1, 2016
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Jeremy D. Paulsen, Scott W. Wenzel, Rafael Ignacio Giganti, Corey T. Cunningham, Jeffery R. Seidling
  • Publication number: 20120276033
    Abstract: The present invention relates to a single phase temperature management composition. The composition includes from 0.01% to 10% by weight of a neurosensory agent and from 0.01% to 30% by weight of an antiperspirant component. The composition also includes a polar carrier where the polar carrier includes water and monohydric alcohol. The ratio of water to monohydric alcohol ranges from 0.0625:1 to 1.5:1. The compositions of the invention have a viscosity at room temperature of less than 2500 centipoise.
    Type: Application
    Filed: April 28, 2011
    Publication date: November 1, 2012
    Inventors: Jeremy D. Paulsen, Scott W. Wenzel, Rafael Ignacio Giganti, Corey T. Cunningham, Jeffery R. Seidling